Amgen Inc. (AMGN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 244.85 |
| Open | 245.93 |
| Bid | 243.10 x 2200 |
| Ask | 245.18 x 800 |
| Day's range | 243.39 - 247.58 |
| 52-week range | 198.64 - 258.45 |
| Volume | |
| Avg. volume | 3,310,046 |
| Market cap | 130.083B |
| Beta (5Y monthly) | 0.57 |
| PE ratio (TTM) | 24.06 |
| EPS (TTM) | 10.12 |
| Earnings date | 01 Aug 2022 - 05 Aug 2022 |
| Forward dividend & yield | 7.76 (3.25%) |
| Ex-dividend date | 16 May 2022 |
| 1y target est | 250.03 |
- Zacks
Amgen (AMGN) Stock Moves -0.21%: What You Should Know
Amgen (AMGN) closed the most recent trading day at $244.85, moving -0.21% from the previous trading session.
- Motley Fool
2 Stocks That Could Survive the Next Recession
Let's look at two companies that fit the bill: Amgen (NASDAQ: AMGN) and Microsoft (NASDAQ: MSFT). Biotech Amgen has been around since 1980, and in that time the company has survived several recessions. In the first quarter, Amgen's revenue increased by a respectable 6% year over year to $6.2 billion.
- Zacks
AbbVie (ABBV) Files Qulipta sNDA for Chronic Migraine Prevention
With the latest approval for chronic migraine prevention, AbbVie's(ABBV) Qulipta becomes the only CGRP receptor antagonist approved for a broad preventive treatment of migraine indication.
© 2022 Yahoo. All rights reserved.
